JP2008513036A - マルチプレックスpcrによるrhd及びaboの遺伝子型決定 - Google Patents
マルチプレックスpcrによるrhd及びaboの遺伝子型決定 Download PDFInfo
- Publication number
- JP2008513036A JP2008513036A JP2007532957A JP2007532957A JP2008513036A JP 2008513036 A JP2008513036 A JP 2008513036A JP 2007532957 A JP2007532957 A JP 2007532957A JP 2007532957 A JP2007532957 A JP 2007532957A JP 2008513036 A JP2008513036 A JP 2008513036A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- rhd
- abo
- gene nucleic
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003205 genotyping method Methods 0.000 title claims description 24
- 238000007403 mPCR Methods 0.000 title claims description 23
- 101150108975 Rhd gene Proteins 0.000 claims abstract description 60
- 101150099178 abo gene Proteins 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims description 132
- 108020004707 nucleic acids Proteins 0.000 claims description 96
- 102000039446 nucleic acids Human genes 0.000 claims description 96
- 150000007523 nucleic acids Chemical class 0.000 claims description 96
- 102100027544 Blood group Rh(D) polypeptide Human genes 0.000 claims description 78
- 210000004369 blood Anatomy 0.000 claims description 75
- 239000008280 blood Substances 0.000 claims description 75
- 108090000623 proteins and genes Proteins 0.000 claims description 38
- 108020004414 DNA Proteins 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 108700024394 Exon Proteins 0.000 claims description 16
- 238000004458 analytical method Methods 0.000 claims description 16
- 238000000137 annealing Methods 0.000 claims description 14
- 239000000523 sample Substances 0.000 claims description 11
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 6
- 239000002853 nucleic acid probe Substances 0.000 claims description 6
- 102100035893 CD151 antigen Human genes 0.000 claims description 4
- 101000946874 Homo sapiens CD151 antigen Proteins 0.000 claims description 4
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 claims description 4
- 108010056664 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims 1
- 230000003321 amplification Effects 0.000 abstract description 35
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 35
- 238000003752 polymerase chain reaction Methods 0.000 description 55
- 108700028369 Alleles Proteins 0.000 description 22
- 102100038341 Blood group Rh(CE) polypeptide Human genes 0.000 description 15
- 101000666610 Homo sapiens Blood group Rh(CE) polypeptide Proteins 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 239000000427 antigen Substances 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 230000004544 DNA amplification Effects 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 230000000405 serological effect Effects 0.000 description 6
- 108091093088 Amplicon Proteins 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000000539 dimer Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 208000003441 Transfusion reaction Diseases 0.000 description 4
- 230000000735 allogeneic effect Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 108700023372 Glycosyltransferases Proteins 0.000 description 3
- 102000051366 Glycosyltransferases Human genes 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 238000009582 blood typing Methods 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 101150098072 20 gene Proteins 0.000 description 1
- 101710157236 41 kDa protein Proteins 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 108091023043 Alu Element Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150032892 RHCE gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 101150100366 end gene Proteins 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 102220039232 rs515726180 Human genes 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0421136A GB0421136D0 (en) | 2004-09-22 | 2004-09-22 | Sequences |
| GB0505983A GB0505983D0 (en) | 2005-03-23 | 2005-03-23 | Gene analysis |
| PCT/GB2005/003659 WO2006032897A2 (en) | 2004-09-22 | 2005-09-22 | Rhd and abo genotyping by multiplex pcr |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008513036A true JP2008513036A (ja) | 2008-05-01 |
| JP2008513036A5 JP2008513036A5 (enExample) | 2008-11-13 |
Family
ID=35998457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532957A Pending JP2008513036A (ja) | 2004-09-22 | 2005-09-22 | マルチプレックスpcrによるrhd及びaboの遺伝子型決定 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090186340A1 (enExample) |
| EP (1) | EP1802767A2 (enExample) |
| JP (1) | JP2008513036A (enExample) |
| CA (1) | CA2581240A1 (enExample) |
| ES (1) | ES2302667T1 (enExample) |
| WO (1) | WO2006032897A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1591534A1 (en) | 2004-04-01 | 2005-11-02 | Stichting Sanquin Bloedvoorziening | A method of genotyping blood cell antigens and a kit suitable for genotyping blood cell antigens |
| AU2008213634B2 (en) * | 2007-02-08 | 2013-09-05 | Sequenom, Inc. | Nucleic acid-based tests for RhD typing, gender determination and nucleic acid quantification |
| WO2009130797A1 (ja) * | 2008-04-22 | 2009-10-29 | 東洋鋼鈑株式会社 | Abo式血液型を判定するためのプローブセット |
| US20110070590A1 (en) | 2009-09-22 | 2011-03-24 | Jan Rohozinski | Primers and Methods for Determining RhD Zygosity |
| GB201008125D0 (en) * | 2010-05-14 | 2010-06-30 | Biofortuna Ltd | Tissue typing assays and kits |
| EP2471949B1 (en) * | 2010-12-31 | 2013-12-25 | Progenika Biopharma, S.A. | Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W) |
| EP2721171A1 (en) * | 2011-06-17 | 2014-04-23 | Progenika Biopharma, S.A. | Discrimination of blood type variants |
| US20160010153A1 (en) * | 2013-03-15 | 2016-01-14 | Life Technologies Corporation | Novel compositions, methods and kits for blood typing |
| CN103361422B (zh) * | 2013-05-24 | 2014-12-17 | 浙江工商大学 | 一种鉴别掺假肉及其制品的多重pcr快速检测方法 |
| CN112029842B (zh) * | 2020-08-31 | 2021-04-27 | 深圳市血液中心(深圳市输血医学研究所) | 一种基于高通量测序进行abo血型基因分型的试剂盒和方法 |
| CN118291605A (zh) * | 2024-04-10 | 2024-07-05 | 深圳市血液中心(深圳市输血医学研究所) | 一种基于ngs的多系统红细胞血型基因分型方法和试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882856A (en) * | 1995-06-07 | 1999-03-16 | Genzyme Corporation | Universal primer sequence for multiplex DNA amplification |
| US6265557B1 (en) * | 1997-05-09 | 2001-07-24 | Loma Linda University Medical Center | ABO histo-blood group O alleles of the baboon |
| ES2241195T3 (es) * | 1998-01-23 | 2005-10-16 | Drk Blutspendedienst Baden-Wurttemberg Ggmbh | Nuevas moleculas de acidos nucleicos correlacionadas con el fenotipo debil d rhesus. |
| AU2001242507A1 (en) * | 2000-04-20 | 2001-11-07 | Adnagen Ag | Method, diagnostic kit and microarray for determining the rhesus factor |
| EP1591534A1 (en) * | 2004-04-01 | 2005-11-02 | Stichting Sanquin Bloedvoorziening | A method of genotyping blood cell antigens and a kit suitable for genotyping blood cell antigens |
-
2005
- 2005-09-22 WO PCT/GB2005/003659 patent/WO2006032897A2/en not_active Ceased
- 2005-09-22 CA CA002581240A patent/CA2581240A1/en not_active Abandoned
- 2005-09-22 EP EP05786348A patent/EP1802767A2/en not_active Withdrawn
- 2005-09-22 US US11/663,624 patent/US20090186340A1/en not_active Abandoned
- 2005-09-22 JP JP2007532957A patent/JP2008513036A/ja active Pending
- 2005-09-22 ES ES05786348T patent/ES2302667T1/es active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20090186340A1 (en) | 2009-07-23 |
| WO2006032897A3 (en) | 2006-09-28 |
| EP1802767A2 (en) | 2007-07-04 |
| ES2302667T1 (es) | 2008-08-01 |
| WO2006032897A2 (en) | 2006-03-30 |
| CA2581240A1 (en) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hyland et al. | Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes | |
| Lan et al. | Genetic polymorphism of RhD-negative associated haplotypes in the Chinese | |
| Irshaid et al. | Genomic characterization of the Kidd blood group gene: Different molecular basis of the Jk (a–b–) phenotypein Polynesians and Finns | |
| Quirino et al. | Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping | |
| Rearden et al. | Glycophorin B and glycophorin E genes arose from the glycophorin A ancestral gene via two duplications during primate evolution. | |
| CN116411059B (zh) | 一种引发溶血性输血反应的类孟买表型的snp位点、应用及试剂 | |
| JP2008513036A (ja) | マルチプレックスpcrによるrhd及びaboの遺伝子型決定 | |
| Silvy et al. | Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles | |
| Tanaka et al. | High-resolution melting analysis for genotyping Duffy, Kidd and Diego blood group antigens | |
| JP2003513620A (ja) | Rhd陰性遺伝子座の分子構造 | |
| AU2002223498B2 (en) | Genetic test for the identification of carriers of complex vertebral malformations in cattle | |
| JP2011500062A (ja) | 血液型群遺伝子の検出 | |
| Sellami et al. | Duffy blood group system genotyping in an urban Tunisian population | |
| TWI479024B (zh) | 檢測p/p血型的方法及其檢測套組 | |
| EP2471949B1 (en) | Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W) | |
| KR102063486B1 (ko) | Rnf213 단일염기다형성과 한국인 모야모야병 발병 위험도의 연관성 | |
| CN116287321B (zh) | 一种与免疫性溶血性输血反应相关的h血型系统抗原缺失的snp位点、应用及试剂 | |
| EP2707497B1 (en) | Detecting the brachyspina mutation | |
| EP3545102B1 (en) | Determination of the genotype underlying the s-s-u- phenotype of the mnss blood group system | |
| US7833710B2 (en) | Polynucleotide associated with breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing breast cancer using the same | |
| Rahim et al. | Co-inheritance of α-and β-thalassemia in Khuzestan Province, Iran | |
| Höher et al. | Identification of ACKR1 variants associated with altered Duffy phenotype expression in blood donors from southern Brazil | |
| EP2904107B1 (en) | Methods for vel blood group typing | |
| WO1993005179A1 (en) | A method for discriminating and identifying alleles in complex loci | |
| JP5493359B2 (ja) | 方法、キット、ポリヌクレオチドの妊孕可能性の推定又は不妊症の原因の同定のための使用、ポリペプチドの妊孕可能性の推定又は不妊症の原因の同定のための使用、及び抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080922 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080922 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20090730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090731 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110517 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110817 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110824 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111115 |